Viewing Study NCT00032903


Ignite Creation Date: 2025-12-24 @ 7:48 PM
Ignite Modification Date: 2026-01-21 @ 3:57 PM
Study NCT ID: NCT00032903
Status: COMPLETED
Last Update Posted: 2009-06-03
First Post: 2002-04-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Malignant Glioma.
Sponsor: Sigma-Tau Research, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ST 01-402
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View